Foxp3 expression in duodenal mucosa in pediatric patients with celiac disease

Pathobiology

Volumn 77, Issue 6, 2011, Pages 328-334

  Brazowski, Eli ^a   Cohen, Shlomi ^b   Yaron, Ayala ^b   Filip, Irina ^a   Eisenthal, Avi ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Celiac disease; FOXP3; Immunohistochemistry; Regulatory T cells

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CELL ACTIVITY; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM MUCOSA; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH BIOPSY; TISSUE SECTION;

ADOLESCENT; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DUODENUM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INTESTINAL MUCOSA; LYMPHOCYTE SUBSETS; MALE; T-LYMPHOCYTES, REGULATORY; TRANSGLUTAMINASES;

EID: 79251573538     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322049     Document Type: Article

References (33)

1. Ciclitira PJ, Johnson MW, Dewar DH, Ellis HJ: The pathogenesis of coeliac disease. Mol Aspects Med 2005;26:421-458.
2. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K: Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-292.
3. Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M: Interleukin 15 mediates epithelialchanges in celiac disease. Gastroenterology 2000;119:996-1006.
4. Stenberg P, Roth EB, Sjöberg K: Transglutaminase and the pathogenesis of coeliac disease. Eur J Intern Med 2008;19:83-91.
5. Schuppan D, Junker Y, Barisani D: Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009;137:1912-1933.
6. De Nitto D, Monteleone I, Franzè E, Pallone F, Monteleone G: Involvement of interleukin-15 and interleukin-21, two gammachain-related cytokines, in celiac disease. World J Gastroenterol 2009;15:4609-4614.
7. Mazzarella G, Stefanile R, Camarca A, Giliberti P, Cosentini E, Marano C, Iaquinto G, Giardullo N, Auricchio S, Sette A, Troncone R, Gianfrani C: Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology 2008;134:1017-1027.
8. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
9. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005;22:329-341.
10. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
11. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
12. Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4:337-342.
13. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-21.
14. Fehervari Z, Sakaguchi S: CD4 Tregs and immune control. J Clin Invest 2004;114:1209-1217.
15. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ: Cutting edge: contact-mediated suppression by CD4CD25 regulatory cells involves a granzyme B-dependent, perforinindependent mechanism. J Immunol 2005;174:1783-1786.
16. Wang L: Adaptive Treg generation by DCs and their functional analysis. Methods Mol Biol 2010;595:403-412.
17. Lan RY, Ansari AA, Lian ZX, Gershwin ME: Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev 2005;4:351-363.
18. Beyer M, Schultze J: Regulatory T cells in cancer. Blood 2006;108:804-811.
19. Imamichi H, Sereti I, Lane HC: IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3. Eur J Immunol 2008;38:1621-1630.
20. Yates J, Rovis F, Mitchell P, Afzali B, Tsang J Y, Garin M, Lechler RI, Lombardi G, Garden OA: The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol 2007;19:785-799.
21. Benito-Miguel M, García-Carmona Y, Balsa A, Pérez de Ayala C, Cobo-Ibáñez T, Martín-Mola E, Miranda-Carús ME: A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25-responder T cells. J Immunol 2009;183:8268-8279.
22. Ma LJ, Acero LF, Zal T, Schluns KS: Transpresentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs. J Immunol 2009;183:1044-1054.
23. Hüe S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S: A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-377.
24. Marsh MN, Crowe PT: Morphology of the mucosal lesion in gluten sensitivity. Baillières Clin Gastroenterol 1995;9:273-293.
25. Brazowski E, Dotan I, Tulchinsky H, Philip I, Eisenthal A: Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouchanal anastomosis (IPAA). Pathol Res Pract 2009;205:551-558.
26. Parizade M, Bujanover Y, Weiss B, Nachmias V, Shainberg B: Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol 2009;16:1576-1582.
27. Sarigul M, Yazisiz V, Bassorgun CI, Ulker M, Avci AB, Erbasan F, Gelen T, Gorczynski RM, Terzioglu E: The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome. Lupus 2010;19:138-145.
28. Kaka AS, Shaffer DR, Hartmaier R, Leen AM, Lu A, Bear A, Rooney CM, Foster AE: Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes. J Immunother 2009;32:726-736.
29. Takaku S, Terabe M, Ambrosino E, Peng J, Lonning S, McPherson JM, Berzofsky JA: Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells. Int J Cancer 2010;126:1666-1674.
30. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, Osella-Abate S, De Simone C, Marzano A, Bernengo MG, Fabbri P, Caproni M: Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol 2010;162:1056-1063.
31. Correale J, Villa A: Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis. Ann Neurol 2010;67:625-638.
32. Benito-Miguel M, García-Carmona Y, Balsa A, Pérez de Ayala C, Cobo-Ibáñez T, Martín-Mola E, Miranda-Carús ME: A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25-responder T cells. J Immunol 2009;183:8268-8279.
33. Sugita J, Tanaka J, Yasumoto A, Shiratori S, Wakasa K, Kikuchi M, Shigematsu A, Kondo T, Asaka M, Imamura M: Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells. Ann Hematol 2010;89:115-120.